Aiberry, a Seattle, WA-based artificial intelligence (AI)-powered mental health screening pioneer, announced that it secured $8 million in seed funding, bringing its total raised to $10 million.
The round was led by Confluence Capital Group, Inc. (CCG), with participation from the VC fund Ascension AI.
The new funds will be used to drive the rapid adoption of a new digital platform that eliminates inaccuracy and bias in the identification of people suffering from mental health disorders
Aiberry uses an AI-powered therapeutic assistant to conduct a conversation to detect mental health disorders by analyzing what is being said, the speech patterns being used, and even subtle changes in facial expressions.
Its platform enables screenings in a wide range of settings, from doctors’ offices to schools, workplaces, or even homes. Its AI-powered therapeutic assistant has a gentle voice and inviting manner that makes users feel at ease and it is available at any time of day or night.
“Early identification and prevention have long been a challenge when it comes to mental health in the U.S.,” said Aiberry co-CEO Linda Chung. “While many platforms have been developed to provide services ranging from preventative care to self-care and even clinical care, the intake process and progress monitoring has failed to advance. Aiberry is an ideal partner for existing digital health platforms and corporate wellness programs, especially in an era where people are becoming increasingly knowledgeable and proactive when it comes to their mental health and wellness.”
“I would like to thank our investors, whose support is enabling us to rapidly establish trust among patients, consumers, and providers by engaging with psychiatrists, psychologists, social workers, licensed mental health counselors, and others who assess and treat mental health disorders,” said Aiberry co-CEO Johan Bjorklund. “The validation the platform is receiving from the clinical community is critical to the rapid expansion of services into larger but less clinical settings including corporate wellness companies and digital health platforms.”
Company: Aiberry, Inc.
Round: Seed Round
Funding Month: March 2023
Lead Investors: Confluence Capital Group, Inc.
Additional Investors: Ascension AI
Company Website: https://aiberry.io/
Software Category: Mental Health Screening Solution
About the Company: Aiberry is a mental health screening solution that improves efficiency and saves time for healthcare providers. Aiberry's platform offers quantifiable and objective outcomes, tracked over time, that can provide a more reliable measure of success. Aiberry gathers the information and presents it in a dashboard that provides a risk score for mental health conditions including depression, anxiety, and suicidal ideation. It also provides insights into mood, concentration, and energy levels. This allows organizations to easily determine which mental health resource is the best investment for their specific needs and goals. Its cutting-edge AI technology is based on two decades of research bundled into a powerful solution that helps providers better serve their patients. Its Machine Learning (ML) pipelines are designed to eliminate biases, including those related to age, gender, sexual orientation, and race.